TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
KPTI

Karyopharm Therapeutics Inc

Healthcare · Biotechnology

1.60$ -6.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Karyopharm Therapeutics Inc (KPTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 146 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement KPTI
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.2 0.6 0.4 0.2 0.3 0.2 1.6 30 41 108 210 157 146 145 146
10 14 34 60 98 87 107 161 2.4 2.7 3.4 5.2 4.9 6.0 5.9
0.2 -13 0.4 -60 0.3 0.2 1.6 -131 38 105 206 152 141 139 140
8.6 14 28 60 98 87 107 161 122 151 161 149 139 143 126
1.8 2.4 5.9 16 22 24 25 49 105 126 144 145 132 115 105
10 17 34 76 119 111 132 210 228 277 305 294 271 259 231
-10 -16 -34 -76 -119 -111 -131 -180 -189 -172 -98 -142 -130 -119 -91
0.0 0.0 0.0 0.0 0.9 1.3 1.6 2.5 16 27 26 25 24 37 46
-10 -16 -34 -76 -118 -109 -129 -178 -200 -196 -124 -165 -143 -76 -196
– 0.0 0.0 -0.1 -0.9 0.1 0.1 0.0 0.0 0.3 0.3 0.4 0.3 0.1 0.0
-10 -16 -34 -76 -118 -110 -129 -178 -200 -196 -124 -165 -143 -76 -196
-10 -16 -34 -75 -118 -110 -130 -175 -183 -168 -97 -139 -118 -39 -150

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?